The US Senate confirmed Dr. Erica Schwartz as director of the Centers for Disease Control and Prevention on August 5, 2026, in a 51-44 vote that fell largely along party lines (The Hill). Schwartz, 54, becomes the 22nd leader of the Atlanta-based agency (Sun-Sentinel) and the first permanent CDC director since Susan Monarez departed the role (The Guardian).

The CDC, the federal agency responsible for protecting public health through disease prevention and control, has operated without a confirmed leader for much of the past two years. Schwartz was President Donald Trump's third pick for the position, arriving after two prior nominees failed to reach confirmation. The first nominee, former Florida congressman David Weldon, was withdrawn by the White House in March 2025 just before his scheduled confirmation hearing. Trump's second choice, Susan Monarez, was fired by Health and Human Services Secretary Robert F. Kennedy Jr. in 2025 after less than a month on the job, following a clash over vaccine policy (The Guardian). Schwartz's nomination was formally listed under Senate designation PN932-119, naming her as a Florida resident to serve as CDC Director vice Susan Monarez (Senate HELP Committee).

The Senate Committee on Health, Education, Labor and Pensions — known as the HELP Committee — held Schwartz's confirmation hearing on July 15, 2026 (Senate HELP Committee). During that hearing, senators pressed Schwartz on whether she would resist pressure from the health secretary to erode the scientific consensus around vaccines. She replied that she "will never betray the science" (The Guardian). That exchange carried particular weight given Monarez's dismissal over vaccine policy differences with Kennedy. Schwartz also stated during the confirmation process that Kennedy "will absolutely allow me to be CDC director" (The Guardian).

The confirmation vote reflected the partisan divide that has come to characterize public-health appointments. Senator Tim Kaine of Virginia was the sole Democrat to vote in favor of Schwartz (The Guardian). On the Republican side, Senator Bill Cassidy of Louisiana, a physician who chairs the Senate HELP Committee, announced his support for the nomination (The Guardian). The Senate had previously held a cloture vote — a procedural step to end debate and move to a final vote — before the final roll call (Senate Daily Press.

Schwartz brings a career grounded in uniformed public health. She served as deputy surgeon general during Trump's first term. She is a Navy veteran who served in the US Public Health Service detailed to the Coast Guard, where she rose to become the force's chief medical officer (The Guardian).

Her military and Public Health Service background distinguishes her from the two prior nominees in this cycle. Weldon was a former congressman with a legislative track record on vaccine safety issues. Monarez's tenure was cut short by direct intervention from Kennedy, whose own views on vaccines have been a source of controversy within the public-health establishment. Schwartz's pledge at her hearing to uphold scientific integrity, combined with her assertion that Kennedy would grant her autonomy, positioned her as a nominee who could satisfy both a White House demanding loyalty and a Senate concerned about political interference at the CDC.

The broader context here is an agency that has operated without a confirmed leader through a prolonged period of political turbulence. The CDC went through three nominees in roughly eighteen months before Schwartz's confirmation. The succession of withdrawals and dismissals reflects the degree to which the CDC directorship has become entangled in debates over vaccine policy, agency independence, and the relationship between career scientists and political leadership at HHS. Schwartz's confirmation restores a permanent director to the agency, but the conditions she described at her hearing — an HHS secretary whose vaccine stance prompted the firing of her predecessor — will shape the environment in which she operates.